Ke Liu
Impact in
- Biotechnology top 0.5%
- Cancer Research and Treatments
- Molecular Biology top 1%
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- Lipid Membrane Structure and Behavior
- RNA modifications and cancer
Papers in
-
- Advanced biosensing and bioanalysis techniques 24
- RNA Interference and Gene Delivery 17
- Natural product bioactivities and synthesis 13
- RNA modifications and cancer 13
- Oncology 52
- Peptidase Inhibition and Analysis 14
- Co-authors
- Claudia Gravekamp (1 shared paper)David Bermudes (1 shared paper)Shibin Zhou (1 shared paper)Todd R. Graham (7 shared papers)Fosong Wang (3 shared papers)Xianhong Wang (3 shared papers)Fenghua Fu (4 shared papers)Shaowei Chen (5 shared papers)
- Journals
- Cancer Research (6 papers)Scientific Reports (6 papers)Nature Communications (5 papers)Drug Metabolism and Disposition (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ke Liu
396 papers receiving 10.5k citations
Ke Liu's Hit Papers
Peers
Comparison fields: 5 of 186
- Biotechnology 722
- Molecular Biology 4.6k
- Cancer Research 733
- Cell Biology 780
- Oncology 1.1k
Countries citing papers authored by Ke Liu
This map shows the geographic impact of Ke Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Liu more than expected).
Fields of papers citing papers by Ke Liu
This network shows the impact of papers produced by Ke Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Liu. The network helps show where Ke Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 415 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour-targeting bacteria engineered to fight cancer Hit paper breakdown → | 2018 | 650 |
| 2 | 2018 | 233 | |
| 3 | 2009 | 220 | |
| 4 | 2015 | 178 | |
| 5 | 2016 | 150 | |
| 6 | 2002 | 146 | |
| 7 | 2021 | 144 | |
| 8 | 2022 | 140 | |
| 9 | 2021 | 137 | |
| 10 | 2010 | 131 | |
| 11 | 2010 | 130 | |
| 12 | 2013 | 122 | |
| 13 | 2020 | 121 | |
| 14 | 2009 | 119 | |
| 15 | 2021 | 119 | |
| 16 | 2022 | 117 | |
| 17 | 2008 | 112 | |
| 18 | 2003 | 104 | |
| 19 | 2005 | 103 | |
| 20 | 2020 | 103 |
About Ke Liu
Ke Liu is a scholar working on Molecular Biology, Oncology, Electrical and Electronic Engineering, Biomedical Engineering and Plant Science, having authored 415 papers that have together received 10.7k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (24 papers), RNA Interference and Gene Delivery (17 papers), Peptidase Inhibition and Analysis (14 papers), Natural product bioactivities and synthesis (13 papers), Endoplasmic Reticulum Stress and Disease (13 papers), RNA modifications and cancer (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cellular transport and secretion (11 papers). The work is most often cited by research in Biotechnology (722 citations), Molecular Biology (4.6k citations), Cancer Research (733 citations), Cell Biology (780 citations) and Oncology (1.1k citations). Ke Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Claudia Gravekamp, David Bermudes, Shibin Zhou, Todd R. Graham, Fosong Wang, Xianhong Wang, Fenghua Fu, Shaowei Chen, Zhaolin Hua and Meidong Liu. Their work appears in journals such as Cancer Research, Scientific Reports, Nature Communications, Drug Metabolism and Disposition and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.